75834-295-01 |
75834-295 |
HUMAN PRESCRIPTION DRUG |
Erythromycin Ethylsuccinate |
Erythromycin Ethylsuccinate |
SUSPENSION |
ORAL |
20230201 |
N/A |
ANDA |
ANDA216212 |
Nivagen Pharmaceuticals, Inc. |
ERYTHROMYCIN ETHYLSUCCINATE |
200 mg/5mL |
100 mL in 1 BOTTLE (75834-295-01) |
71209-102-21 |
71209-102 |
HUMAN PRESCRIPTION DRUG |
Erythromycin ethylsuccinate |
Erythromycin ethylsuccinate |
FOR SUSPENSION |
ORAL |
20221121 |
N/A |
ANDA |
ANDA216212 |
Cadila Pharmaceuticals Limited |
ERYTHROMYCIN ETHYLSUCCINATE |
200 mg/5mL |
100 mL in 1 BOTTLE (71209-102-21) |
71209-103-21 |
71209-103 |
HUMAN PRESCRIPTION DRUG |
Erythromycin ethylsuccinate |
Erythromycin ethylsuccinate |
FOR SUSPENSION |
ORAL |
20221121 |
N/A |
ANDA |
ANDA216212 |
Cadila Pharmaceuticals Limited |
ERYTHROMYCIN ETHYLSUCCINATE |
400 mg/5mL |
100 mL in 1 BOTTLE (71209-103-21) |
75834-294-01 |
75834-294 |
HUMAN PRESCRIPTION DRUG |
Erythromycin Ethylsuccinate |
Erythromycin Ethylsuccinate |
SUSPENSION |
ORAL |
20230201 |
N/A |
ANDA |
ANDA216212 |
Nivagen Pharmaceuticals, Inc. |
ERYTHROMYCIN ETHYLSUCCINATE |
400 mg/5mL |
100 mL in 1 BOTTLE (75834-294-01) |